A peroxisome proliferator-activated receptor γ agonist influenced daily profile of energy expenditure in genetically obese diabetic rats

Japanese Journal of Pharmacology

Volumn 88, Issue 3, 2002, Pages 279-284

  Yoshida, Yuki ^a   Ichikawa, Mineko ^a   Ohta, Minoru ^a   Kanai, Setsuko ^a   Kobayashi, Mikako ^a   Ichimaru, Yuhei ^a   Shimazoe, Takao ^a   Watanabe, Shigenori ^a   Funakoshi, Akihiro ^a   Miyasaka, Kyoko ^a  

^a TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

Author keywords

Energy expenditure; Non insulin dependent diabetes mellitus; Obesity; Peroxisome proliferator activated receptor

Indexed keywords

ANTIDIABETIC AGENT; FAT; GLUCOSE; HEMOGLOBIN A1C; INSULIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PIOGLITAZONE; PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CIRCADIAN RHYTHM; COMBUSTION; CONTROLLED STUDY; DIETARY INTAKE; DISEASE SEVERITY; DRUG EFFECT; ENERGY CONVERSION; ENERGY EXPENDITURE; GLUCOSE METABOLISM; HEMOGLOBIN DETERMINATION; INSULIN BLOOD LEVEL; LIPID BLOOD LEVEL; LIPID METABOLISM; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PROTEIN BLOOD LEVEL; RAT; RAT STRAIN; VISCERA;

EID: 0036221602     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.88.279     Document Type: Article

References (29)

1. Spontaneous long-term hyperglycemic rat with diabetic complications
2. An animal model of congenital defect of gene expression of cholecystokinin (CCK)-A receptor
3. Disrupted cholecystokinin type-A receptor (CCK-AR) gene in OLETF rats
4. Lack of satiety effect of cholecystokinin (CCK) in a new rat model not expressing the CCK-A receptor gene
5. Disappearance of diurnal rhythm of energy expenditure in genetically diabetic obese rats
6. The diurnal rhythm of energy expenditure differs between obese and glucose-intolerant rats and streptozotocin-induced diabetic rats
7. Obesity is necessary but not sufficient for the development of diabetes mellitus
8. Is caloric restriction effective in preventing diabetes mellitus in the Otsuka Long Evans Tokushima Fatty rats, a model of spontaneous non-insulin-dependent diabetes mellitus?
9. Exercise training has a long-lasting effect on prevention of non-insulin-dependent diabetes mellitus in Otsuka-Long-Evans-Tokushima Fatty rats
10. A PPARγ agonist improved diabetic state via decreasing TNF-α without any change including obesity in genetically obese diabetic rats
11. An antidiabetic thiazolidinekione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPARγ)
12. Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression
13. PPARγ, the ultimate thrifty gene
14. VLDL triglyceride kinetics in Wistar Fatty rats, an animal model of NIDDM
15. Effects of nitrogen and energy metabolism on body weight in later life of male Wistar rats consuming a constant amount of food
16. Protein glycosylation in diabetes mellitus: A review of laboratory measurements and of their clinical utility
17. Enzymatic determination of total serum cholesterol
18. Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide
19. Pancreatic endocrine dysfunction in rats not expressing the cholecystokinin-A receptor
20. Pioglitazone time-dependently reduces tumor necrosis factor-alpha level in muscle and improves metabolic abnormalities in Wistar fatty rats
21. Circadian system phase - An aspect of temporal morphology; Procedures and illustrative examples
22. Least square multivariate cosine spectrum analysis for ambulatory blood pressure and heart rate
23. PPAR-γ: Adipogenic regulator and thiazolidinedione receptor
24. Adipogenesis and obesity: Rounding out the big picture
25. Adipose expression of tumor necrosis factor-α: Direct role in obesity-linked insulin resistance
26. Pioglitazone time-dependently reduces tumor necrosis factor-alpha level in muscle and improves metabolic abnormalities in Wistar fatty rats
27. Troglitazone increases the number of small adipocytes without the changes of white adipose tissue mass in obese Zucker rats
28. Antidiabetic thiazolidinediones block the inhibitory effect of tumor necrosis factor-α on differentiation, insulin-stimulated glucose uptake and gene expression in 3T3-L1 cells
29. PPAR-γ agonists inhibit production of monocyte inflammatory cytokines